RogerBlack
Senior Member
- Messages
- 902
Assuming for the moment rituximab isn't a cure for most.
There is lots of biochemical work going on at the moment, and it seems not wholly unreasonable that a root cause may be found in 2-5 years.
After this root cause is found, nothing changes rapidly unless there is an available drug that is safe, well tolerated and cheap.
If, for example it was found that 100g of really good mint chocolate a day cured CFS. (or more seriously, some out of patent drug for something that's cheap to make, and has gone through all safety trials, in many countries doctors could prescribe this immediately off-label.
If this is not the case, then we're looking at more like 17-25 years, once a cause is found, to investigate possible drug targets, synthesise a new compound, see that it is safe in animals, see it's safe in a small number of healthy people, try it in a small number of ill people, then a larger number, and finally a full trial before release.
www.fdareview.org/03_drug_development.php
Funding is also an issue - this will take around $100M to conduct the trials only.
There is lots of biochemical work going on at the moment, and it seems not wholly unreasonable that a root cause may be found in 2-5 years.
After this root cause is found, nothing changes rapidly unless there is an available drug that is safe, well tolerated and cheap.
If, for example it was found that 100g of really good mint chocolate a day cured CFS. (or more seriously, some out of patent drug for something that's cheap to make, and has gone through all safety trials, in many countries doctors could prescribe this immediately off-label.
If this is not the case, then we're looking at more like 17-25 years, once a cause is found, to investigate possible drug targets, synthesise a new compound, see that it is safe in animals, see it's safe in a small number of healthy people, try it in a small number of ill people, then a larger number, and finally a full trial before release.
www.fdareview.org/03_drug_development.php
Funding is also an issue - this will take around $100M to conduct the trials only.